A Case of Small Cell Lung Cancer Transformation from EGFR-Mutant Lung Adenocarcinoma with Primary Resistance to Gefitinib

J Thorac Oncol. 2018 Oct;13(10):e211-e214. doi: 10.1016/j.jtho.2018.05.022.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • ErbB Receptors / genetics
  • Female
  • Gefitinib / pharmacology
  • Gefitinib / therapeutic use*
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Middle Aged
  • Mutation
  • Small Cell Lung Carcinoma / drug therapy*
  • Small Cell Lung Carcinoma / pathology

Substances

  • Antineoplastic Agents
  • EGFR protein, human
  • ErbB Receptors
  • Gefitinib